论文部分内容阅读
对37例膀脱癌患者尿液β—HCG进行检测，结果37例中15例β—HCG≥25iu/1占40.5％（15／37），其中6例≥50iu／1占16.2人％（6／37），5例肿瘤转移者中3例≥100iu／1占60％（3／5），最高1例为600iu／1。初步认为尿β—HCG可作为膀胱癌标志物，在预示肿瘤分化不良、转移方面具有一定的临床价值。
Β-HCG was detected in 37 cases of bladder cancer. The results showed that in 15 of 37 cases, 15.5% (15/37) had β-HCG≥25iu / 1, of which 6 cases ≥50iu / 1 accounted for 16.2% (6 / 37). Of the 5 tumor metastases, 3 cases ≥100iu / 1 accounted for 60% (3/5), and the highest one case was 600iu / 1. Urine β-HCG can be considered as a marker of bladder cancer, which has certain clinical value in predicting the poorly differentiated and metastatic tumor.